A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures.

NCT00425282 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

566

Enrollment

INDUSTRY

Sponsor class

Conditions

Epilepsy
Epilepsy, Focal
Seizure Disorder
Complex Partial Seizures
Epilepsy, Complex Partial

Interventions

DRUG: RWJ-333369

Sponsor

SK Life Science, Inc.